Verrica Pharmaceuticals Inc (NASDAQ:VRCA)
| 3.79 Delayed Data As of Sep 22 |  +0.04 / +1.07%Today’s Change | 2.02 Today|||52-Week Range 8.70 | +37.82% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 5.0K | 10.3K | 40.0K | 41.0K | ||
| Operating Expenses | Gross Income | -5.0K | -10.3K | -40.0K | -41.0K | |
| General Expenses | 7.2M | 8.2M | 8.0M | 7.5M | ||
| Research And Development | 3.5M | 4.9M | 4.5M | 3.9M | ||
| Total Operating Expenses | 7.2M | 8.2M | 8.0M | 7.5M | ||
| Non-Operating Expenses | Operating Income | -7.2M | -8.2M | -8.0M | -7.5M | |
| Other Expenses | -1.0K | 0.00 | 0.00 | -3.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -6.7M | -7.6M | -7.5M | -7.0M | |
| Net Income | -6.7M | -7.6M | -7.5M | -7.0M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 24.8M | 24.8M | 24.9M | 24.9M | |
| Shares To Calculate EPS Diluted | 24.8M | 24.8M | 24.9M | 24.9M | ||
| Earnings Per Share | EPS | -$0.27 | -$0.30 | -$0.30 | -$0.28 | |
| EPS Diluted | -$0.27 | -$0.31 | -$0.30 | -$0.28 | ||
